Linux Laboratories Appoints Avendus to Raise $50-70 Million for Expansion Plans
Published on: Jan. 23, 2026, 10:42 a.m. | Source: scanx.trade
Linux Laboratories has engaged Avendus to raise $50-70 million for expansion, marking its second external funding round since Tata Capital's 2021 investment. The Chennai-based pharmaceutical company specializes in neurology, psychiatry, and dermatology segments, reporting strong FY25 performance with revenue of ₹285.00 crore and net profit of ₹26.00 crore. The funding will support organic growth, acquisitions, and international expansion in India's competitive pharmaceutical market valued at $55 billion.
